253 related articles for article (PubMed ID: 30554892)
1. High prevalence of clinical spondyloarthritis features in patients with hidradenitis suppurativa.
Rondags A; van Straalen KR; Arends S; van der Zee HH; Prens EP; Spoorenberg A; Horváth B
J Am Acad Dermatol; 2019 Feb; 80(2):551-554.e1. PubMed ID: 30554892
[No Abstract] [Full Text] [Related]
2. Association between hidradenitis suppurativa and spondyloarthritis.
Fauconier M; Reguiai Z; Barbe C; Colosio A; Eschard JP; Salmon JH; Direz G
Joint Bone Spine; 2018 Oct; 85(5):593-597. PubMed ID: 28965938
[TBL] [Abstract][Full Text] [Related]
3. Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset.
Denny G; Anadkat MJ
J Am Acad Dermatol; 2016 Sep; 75(3):632-634. PubMed ID: 27543219
[No Abstract] [Full Text] [Related]
4. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation.
Rondags A; Arends S; Wink FR; Horváth B; Spoorenberg A
Semin Arthritis Rheum; 2019 Feb; 48(4):611-617. PubMed ID: 29751976
[TBL] [Abstract][Full Text] [Related]
5. The prevalence of metabolic syndrome in patients with hidradenitis suppurativa.
Gold DA; Reeder VJ; Mahan MG; Hamzavi IH
J Am Acad Dermatol; 2014 Apr; 70(4):699-703. PubMed ID: 24433875
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of hidradenitis suppurativa in Brazil: a population survey.
Ianhez M; Schmitt JV; Miot HA
Int J Dermatol; 2018 May; 57(5):618-620. PubMed ID: 29517130
[No Abstract] [Full Text] [Related]
7. Prevalence of type 2 diabetes mellitus among patients with hidradenitis suppurativa in the United States.
Garg A; Birabaharan M; Strunk A
J Am Acad Dermatol; 2018 Jul; 79(1):71-76. PubMed ID: 29339240
[TBL] [Abstract][Full Text] [Related]
8. Hidradenitis suppurativa (HS) is associated with low socioeconomic status (SES): A cross-sectional reference study.
Deckers IE; Janse IC; van der Zee HH; Nijsten T; Boer J; Horváth B; Prens EP
J Am Acad Dermatol; 2016 Oct; 75(4):755-759.e1. PubMed ID: 27453539
[TBL] [Abstract][Full Text] [Related]
9. Hidradenitis suppurativa: Epidemiology and scope of the problem.
Jemec GB; Kimball AB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
[TBL] [Abstract][Full Text] [Related]
10. Association Between Hidradenitis Suppurativa and Lymphoma.
Tannenbaum R; Strunk A; Garg A
JAMA Dermatol; 2019 May; 155(5):624-625. PubMed ID: 30698627
[TBL] [Abstract][Full Text] [Related]
11. Hidradenitis suppurativa associated with spondyloarthritis -- results from a multicenter national prospective study.
Richette P; Molto A; Viguier M; Dawidowicz K; Hayem G; Nassif A; Wendling D; Aubin F; Lioté F; Bachelez H
J Rheumatol; 2014 Mar; 41(3):490-4. PubMed ID: 24429166
[TBL] [Abstract][Full Text] [Related]
12. Hidradenitis suppurativa and associated factors: still unsolved problems.
Matusiak L; Bieniek A; Szepietowski JC
J Am Acad Dermatol; 2009 Aug; 61(2):362-5. PubMed ID: 19615551
[No Abstract] [Full Text] [Related]
13. Hidradenitis suppurativa, a review of pathogenesis, associations and management. Part 1.
Vekic DA; Frew J; Cains GD
Australas J Dermatol; 2018 Nov; 59(4):267-277. PubMed ID: 29355905
[TBL] [Abstract][Full Text] [Related]
14. Hidradenitis Suppurativa: Estimated Prevalence, Clinical Features, Concomitant Conditions, and Diagnostic Delay in a University Teaching Hospital in Buenos Aires, Argentina.
Zimman S; Comparatore MV; Vulcano AF; Absi ML; Mazzuoccolo LD
Actas Dermosifiliogr (Engl Ed); 2019 May; 110(4):297-302. PubMed ID: 30885385
[TBL] [Abstract][Full Text] [Related]
15. Questionnaire-based diagnosis of hidradenitis suppurativa: specificity, sensitivity and positive predictive value of specific diagnostic questions.
Esmann S; Dufour DN; Jemec GB
Br J Dermatol; 2010 Jul; 163(1):102-6. PubMed ID: 20331444
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic and clinical features of hidradenitis suppurativa.
Parulkar I; Haleem H; Paek SY
Semin Cutan Med Surg; 2017 Jun; 36(2):42-46. PubMed ID: 28538742
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and cutaneous comorbidities of hidradenitis suppurativa in the German working population.
Kirsten N; Zander N; Augustin M
Arch Dermatol Res; 2021 Mar; 313(2):95-99. PubMed ID: 32322958
[TBL] [Abstract][Full Text] [Related]
18. Risk Factors of Sexual Dysfunction in Patients with Hidradenitis Suppurativa: A Cross-Sectional Study.
Cuenca-Barrales C; Molina-Leyva A
Dermatology; 2020; 236(1):37-45. PubMed ID: 31434072
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of concomitant psoriasis and hidradenitis suppurativa (HS): experience of a tertiary medical center.
Patel M; Cohen JM; Wright NA; Merola JF; Qureshi AA; Vleugels RA
J Am Acad Dermatol; 2015 Oct; 73(4):701-2. PubMed ID: 26369843
[No Abstract] [Full Text] [Related]
20. Epidemiology of hidradenitis suppurativa and inflammatory bowel disease: are these two disease associated?
Salgado-Boquete L; Romaní J; Carrión L; Marín-Jiménez I
Actas Dermosifiliogr; 2016 Sep; 107 Suppl 2():8-12. PubMed ID: 28081771
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
